General Information of Drug (ID: DMB4GD9)

Drug Name
IONIS-GCGR-Rx Drug Info
Indication
Disease Entry ICD 11 Status REF
Type 2 diabetes 5A11 Phase 2 [1]
Type-2 diabetes 5A11 Phase 2 [2]
Cross-matching ID
TTD Drug ID
DMB4GD9

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
ISIS-GCGR DMHNYWP Diabetic complication 5A2Y Phase 2 [3]
ISIS 325568 DMEJ4B7 Type-2 diabetes 5A11 Phase 1 [4]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Glucagon receptor messenger RNA (GCGR mRNA) TTLMJSC GLR_HUMAN Inhibitor [1]

References

1 Clinical pipeline report, company report or official report of Ionis Pharmaceuticals.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Clinical pipeline report, company report or official report of ISIS Pharmaceuticals (2011).
4 Design and development of antisense drugs. Expert Opin. Drug Discov. 2008 3(10):1189-1207.